Abstract: A flavoring sheet with an enhanced flavor holding amount and flavor retention and a smoking article including the same are provided. The flavoring sheet according to some embodiments of the present disclosure may include a hydrocolloid material configured to form a sheet, an emulsifier, and a fat-soluble flavoring. The emulsifier may serve as a cross-link between the water-soluble hydrocolloid material and the fat-soluble flavoring and increase a flavor holding amount and flavor retention of the flavoring sheet.

Abstract: Provided is a method of operating a terminal. The method includes determining a profile item applicable to the profile view for the account based on an input received by the terminal and a coordinate indicating a position where the profile item is provided on the profile view. The method includes displaying the profile item on a screen of the terminal based on the determined profile item and the determined coordinate. The method includes receiving an input related to the profile item, and displaying a visual effect corresponding to the input on the screen.

Abstract: A flavoring sheet with improved physical properties, a smoking article including the same, and methods of producing the flavoring sheet and the smoking article are provided. The flavoring sheet according to some embodiments of the present disclosure may include a hydrocolloid material configured to form a sheet, a flavoring, and a plasticizer. The plasticizer can improve physical properties of the flavoring sheet and thus enhance workability of a process of cutting the flavoring sheet.

Abstract: The present application relates to a peptide having protective activity against cell damage caused by particulate matter, and to uses for the peptide.

Abstract: Disclosed herein is a self-assembly brazier. The self-assembly brazier includes: a pair of floor plates arranged bilaterally symmetrical to face each other; a pair of side wall modules having a plurality of side panels disposed to be rotatable, being combined with each other to face each other symmetrically so that a combustion space is formed, and being arranged on upper surfaces of the floor plates to be erected; and a pair of fuel loading parts seated inside lower portions of the side wall modules so that fuel is loaded on the upper surfaces of the fuel loading parts.

Abstract: The present invention relates to: A schizophrenia animal model wherein the model is a mouse in which an anoctamin 1 (ANO1) gene is knocked out in cholinergic neurons of a medial habenula; and a preparation method therefor and the like. The schizophrenia animal model according to the present invention targets the medial habenula which is brain tissue playing a major role in the pathogenesis of schizophrenia, and it has been confirmed that when the ANO1 gene is specifically knocked out in the cholinergic neurons of the medial habenula, positive, negative and cognitive symptoms of schizophrenia are observed, thereby confirming that schizophrenia has been induced. Therefore, the animal model of the present invention is expected to be effectively useful in schizophrenia pathogenesis research and therapeutic agent development and screening.

Abstract: Disclosed herein is a self-assembly brazier for camping. The self-assembly brazier for camping includes: a main body including a base plate arranged on the ground, an ash tray arranged to be spaced apart from the base plate by a pair of support legs vertically arranged at both sides of the base plate, a pair of side coupling wings foldably coupled to both sides of an upper surface of the ash tray, and a storage space formed between the base plate and the ash tray; and a pair of dual panels detachably fit and coupled between the side coupling wings when the side coupling wings are vertically unfolded relative to the ash tray, so as to form a combustion space together with the ash tray. The brazier further includes a combustion plate detachably arranged in the combustion space to which the dual panels are coupled, and having an upper surface on which fuel is arranged.

Abstract: Disclosed herein is a partition wall assembly for a stove. The partition wall assembly for a stove includes a plurality of partition walls (100, 100a, 100b, 100c). Each of the partition walls includes: an outer panel (110) having first air intake holes (111a) formed at a lower portion thereof so that first air is induced; an inner panel (120) coupled to the inside of the outer panel (110), and having an air moving space (119) formed between the outer panel (110) and the inner panel (120) so that the first air induced through the first air intake holes (111a) moves in the air moving space (119) while temperature of the first air is elevated, and second air outlets (121b) formed at an upper portion thereof to discharge the second air with the elevated temperature toward fuel; and a pair of side coupling members (130) disposed at both sides of the outer panel (110) to couple the outer panel (110) and the inner panel (120) with each other.

Abstract: The present invention relates to obesity control by regulating the expression level of TREK1.

Abstract: Disclosed herein is a self-assembly brazier. The self-assembly brazier includes: a pair of floor plates arranged bilaterally symmetrical to face each other; a pair of side wall modules having a plurality of side panels disposed to be rotatable, being combined with each other to face each other symmetrically so that a combustion space is formed, and being arranged on upper surfaces of the floor plates to be erected; and a pair of fuel loading parts seated inside lower portions of the side wall modules so that fuel is loaded on the upper surfaces of the fuel loading parts.

Abstract: Disclosed herein is a self-assembly brazier for camping. The self-assembly brazier for camping includes: a main body including a base plate arranged on the ground, an ash tray arranged to be spaced apart from the base plate by a pair of support legs vertically arranged at both sides of the base plate, a pair of side coupling wings foldably coupled to both sides of an upper surface of the ash tray, and a storage space formed between the base plate and the ash tray; and a pair of dual panels detachably fit and coupled between the side coupling wings when the side coupling wings are vertically unfolded relative to the ash tray, so as to form a combustion space together with the ash tray. The brazier further includes a combustion plate detachably arranged in the combustion space to which the dual panels are coupled, and having an upper surface on which fuel is arranged.

Abstract: Disclosed herein is a partition wall assembly for a stove. The partition wall assembly for a stove includes a plurality of partition walls (100, 100a, 100b, 100c). Each of the partition walls includes: an outer panel (110) having first air intake holes (111a) formed at a lower portion thereof so that first air is induced; an inner panel (120) coupled to the inside of the outer panel (110), and having an air moving space (119) formed between the outer panel (110) and the inner panel (120) so that the first air induced through the first air intake holes (111a) moves in the air moving space (119) while temperature of the first air is elevated, and second air outlets (121b) formed at an upper portion thereof to discharge the second air with the elevated temperature toward fuel; and a pair of side coupling members (130) disposed at both sides of the outer panel (110) to couple the outer panel (110) and the inner panel (120) with each other.

Abstract: The present invention relates to: A schizophrenia animal model wherein the model is a mouse in which an anoctamin 1 (ANO1) gene is knocked out in cholinergic neurons of a medial habenula; and a preparation method therefor and the like. The schizophrenia animal model according to the present invention targets the medial habenula which is brain tissue playing a major role in the pathogenesis of schizophrenia, and it has been confirmed that when the ANO1 gene is specifically knocked out in the cholinergic neurons of the medial habenula, positive, negative and cognitive symptoms of schizophrenia are observed, thereby confirming that schizophrenia has been induced. Therefore, the animal model of the present invention is expected to be effectively useful in schizophrenia pathogenesis research and therapeutic agent development and screening.

Abstract: The present invention relates to a novel phenoxypropanol derivative, represented by the structure of Chemical Formula I, and a racemate thereof, a pharmaceutically acceptable salt thereof, a solvate thereof and a hydrate thereof, wherein * represents an (R)-form or an (S)-form, X is selected from the group consisting of hydrogen, halogen and substituted or unsubstituted straight or branched alkyl having 1 to 4 carbon atoms, and n represents the number of X and an integer of 1 to 5, wherein at least a hydrogen is substituted with halogen in the substituted linear or branched alkyl having 1 to 4 carbon atoms. The derivative can be used for blocking T-type calcium channel and/or TREK channel, and for preventing and/or treating T-type calcium channel- and/or TREK channel-associated diseases.

Abstract: The present invention relates to a novel phenoxypropanol derivative, use thereof for blocking T-type calcium channel and/or TREK channel, and use thereof for preventing and/or treating T-type calcium channel- and/or TREK channel-associated diseases.

Abstract: The present invention investigate the two modes of glutamate release and the releasing rate of glutamate, and thus can provide a useful technique for neuron protection and acceleration of neurotransmission by controlling the glutamate release in astroctye. Thus, the present invention provides an inhibitor of the fast-mode release and/or the slow-mode release of astrocytic glutamate, a screening method of the inhibitor and a pharmaceutical composition or method of ameliorating, preventing and/or treating the disease associated with the over-release of glutamate via the Ca2+-activated anion channel, with the inhibition of fast-mode glutamate release.

Abstract: The present invention investigate the two modes of glutamate release and the releasing rate of glutamate, and thus can provide a useful technique for neuron protection and acceleration of neurotransmission by controlling the glutamate release in astroctye. Thus, the present invention provides an inhibitor of the fast-mode release and/or the slow-mode release of astrocytic glutamate, a screening method of the inhibitor and a pharmaceutical composition or method of ameliorating, preventing and/or treating the disease associated with the over-release of glutamate via the Ca2+-activated anion channel, with the inhibition of fast-mode glutamate release.

Abstract: The present invention relates to a recombinant adenovirus expressing an ?A-crystallin gene, and gene therapy for retinal vascular disease using the recombinant adenovirus. Gene therapy using the recombinant adenovirus comprising an ?A-crystallin gene of the present invention increases the expression level of the ?A-crystallin gene in the damaged retinal pericytes to suppress pericyte loss and death, retinal vascular leakage, and leukocyte adhesion surrounding retinal vessels, thereby protecting the pericytes. Therefore, it can be used for the prevention and treatment of various retinal vascular diseases including diabetic retinopathy.